AHR and neoplasm: Further, among the I3P‐derived metabolites, kynurenic acid (KynA) and indole‐3‐aldehyde (I3A) lead to the activation of the AHR signalling pathway, which might increase the migratory and invasive abilities of tumour cells and reduce CD8+ T cell proliferation [20].